1. Home
  2. TLF vs NCEL Comparison

TLF vs NCEL Comparison

Compare TLF & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.33

Market Cap

18.2M

ML Signal

N/A

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.35

Market Cap

17.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLF
NCEL
Founded
1980
2008
Country
United States
Switzerland
Employees
N/A
4
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
17.2M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
TLF
NCEL
Price
$2.33
$3.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.4K
30.5K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
N/A
EPS
0.03
N/A
Revenue
$76,324,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$78.33
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$1.83
52 Week High
$3.78
$5.12

Technical Indicators

Market Signals
Indicator
TLF
NCEL
Relative Strength Index (RSI) 47.91 50.65
Support Level $2.25 $2.95
Resistance Level $2.45 $3.62
Average True Range (ATR) 0.07 0.23
MACD 0.00 0.00
Stochastic Oscillator 32.35 77.98

Price Performance

Historical Comparison
TLF
NCEL

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: